Vhi webinar sets out framework for healthcare professionals to support patients in making healthcare decisions ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten), 5 ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company’s First ...
1 Department of Cardiology and Internal Medicine, University Hospital of Brazzaville, Brazzaville, Republic of Congo. 2 Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Republic of ...
MANCHESTER, England–(BUSINESS WIRE)–Codethink announced that it has successfully achieved a positive and complete Functional Safety Assessment for the Eclipse Trustable Software Framework (TSF).
Objective This study aimed to determine the proportion of capacity challenges for refusal of care, the risk factors that may trigger challenges to capacity and to consider the implications of ...
Background Cognitive dysfunction is frequently seen in multiple sclerosis (MS). However, there are conflicting findings regarding the factors it is associated with. Objective To investigate the ...
Background: The patient’s somatic health status plays an important role in the factors predisposing to the development of depression. Any disease, especially a chronic one, often associated with pain, ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Semaglutide, a GLP-1 ...
Ohio University's Office of Information Technology is pleased to announce a new option to purchase University-owned devices. A Device Purchasing form is now available for individuals and departments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results